Safety Shot, Inc. SHOT witnessed a surge in shares on Monday following the company’s defiant move to retain a powerhouse law firm to tackle recent turbulence in its stock performance and a contentious short report.
What’s Happening: In a bold move, the company revealed on Monday that it has roped in attorney Mark R. Basile and his short and distort securities litigation firm, The Basile Law Firm P.C., to probe recent developments surrounding the company’s stock performance. The legal warriors are prepared to counter any illicit tactics aimed at harming retail investors. Of particular concern is a recent research paper by Capybara Research.
Brian S. John, CEO of Safety Shot, Inc., stressed, “We are thrilled to have Mr. Basile on our side. We are determined to take legal action against any short and distort campaigns targeting the company, as well as media outlets that irresponsibly disseminated the false and defamatory Capybara Report.”
“Mr. Basile comprehends the detrimental impact of short and distort campaigns on retail shareholders and is leading the charge in our efforts to safeguard the company and its shareholders.”
Related Link: What’s Going On With Symbotic Stock?
SHOT Price Rally: The share price of SHOT catapulted by 29.5%, closing at $4.70, as reported by Benzinga Pro.
Image by Foundry Co from Pixabay